Orthometrix IncOver The Counter Market:OMRX
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Orthometrix Inc | 50.0 | 0.0x | --- |
Decision Diagnostics Corp | 140.0 | 0.0x | --- |
Bionik Laboratories Corp | 10.0 | 0.0x | --- |
American Medical Technologies Inc | 10.0 | 0.0x | --- |
Avitar Inc | 130.0 | 0.0x | --- |
Vasamed Inc | 10.0 | 0.0x | --- |
Company Information
Orthometrix, Inc. markets, sells and services several musculoskeletal product lines used in pharmaceutical research, diagnosis and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy and pain management. The Company offers five product lines. The Company markets, sells and services its products primarily in the United States and Canada. It markets, sells and services its products and devices through two divisions: Healthcare Division and Sports & Fitness Division. The Sports & Fitness Division markets, sells and services the exercise systems, which include the Mini VibraFlex, Mini VibraFlex Plus, VibraFlex 550, among others. The Healthcare Division markets, sells and services include pQCT bone and muscle measurement systems for use in musculoskeletal research applications.
Contact Information
- Headquarters
- 5621 Strand Blvd Ste 111NAPLES, FL, United States 34110-7302
- Phone
- 302-658-7581
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President and Treasurer
- Reynald Bonmati
- Chief Financial Officer
- Neil Koenig
- Director
- Michael Huber
- Director
- Andre-Jacques Neusy
- Director
- William Orr
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.00 |
|---|---|
Revenue (TTM) | $1.5M |
Shares Outstanding | 53.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.02 |
Book Value | $-0.06 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
